$1.37
+0.01 (+0.74%)
Open$1.36
Previous Close$1.36
Day High$1.38
Day Low$1.34
52W High$2.89
52W Low$1.17
Volume—
Avg Volume1.35M
Market Cap335.95M
P/E Ratio—
EPS$-0.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,078.8% upside
Current
$1.37
$1.37
Target
$16.15
$16.15
$10.52
$16.15 avg
$19.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 919.49M | 836.35M | 59.12M |
| Net Income | -15,318,543 | -12,540,193 | 16.50M |
| Profit Margin | -1.7% | -1.6% | 27.9% |
| EBITDA | 42.70M | 36.89M | 25.74M |
| Free Cash Flow | — | — | 14.78M |
| Rev Growth | +9.9% | +9.9% | +13.8% |
| Debt/Equity | 0.15 | 0.15 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |